ATE534395T1 - Verwendung von fettgewebezellen zur einleitung der bildung eines funktionalen gefässnetzes - Google Patents

Verwendung von fettgewebezellen zur einleitung der bildung eines funktionalen gefässnetzes

Info

Publication number
ATE534395T1
ATE534395T1 AT04787313T AT04787313T ATE534395T1 AT E534395 T1 ATE534395 T1 AT E534395T1 AT 04787313 T AT04787313 T AT 04787313T AT 04787313 T AT04787313 T AT 04787313T AT E534395 T1 ATE534395 T1 AT E534395T1
Authority
AT
Austria
Prior art keywords
vascular network
adiative
initiate
formation
tissue cells
Prior art date
Application number
AT04787313T
Other languages
English (en)
Inventor
Louis Casteilla
Jean-Sebastien Silvestre
Valerie Planat-Benard
Bernard Levy
Luc Penicaud
Alain Tedgui
Original Assignee
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Toulouse
Univ Paris Vii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34178812&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE534395(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Toulouse, Univ Paris Vii filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE534395T1 publication Critical patent/ATE534395T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1305—Adipocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/78—Cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04787313T 2003-09-05 2004-09-06 Verwendung von fettgewebezellen zur einleitung der bildung eines funktionalen gefässnetzes ATE534395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0310504A FR2859381B1 (fr) 2003-09-05 2003-09-05 Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel
PCT/FR2004/002258 WO2005025584A1 (fr) 2003-09-05 2004-09-06 Utilisation de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel.

Publications (1)

Publication Number Publication Date
ATE534395T1 true ATE534395T1 (de) 2011-12-15

Family

ID=34178812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787313T ATE534395T1 (de) 2003-09-05 2004-09-06 Verwendung von fettgewebezellen zur einleitung der bildung eines funktionalen gefässnetzes

Country Status (8)

Country Link
US (2) US20070116674A1 (de)
EP (1) EP1663263B1 (de)
JP (1) JP4977463B2 (de)
AT (1) ATE534395T1 (de)
CA (1) CA2537482C (de)
ES (1) ES2378165T3 (de)
FR (1) FR2859381B1 (de)
WO (1) WO2005025584A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
KR100930139B1 (ko) 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050048035A1 (en) 2001-12-07 2005-03-03 Fraser John K. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
EP1878789A4 (de) * 2005-04-14 2008-08-27 Japan As Represented By Genera Aus fett stammende vorläuferzelle und verwendung davon
US8445280B2 (en) * 2006-03-24 2013-05-21 Nortis, Inc. Method for creating perfusable microvessel systems
US7622298B2 (en) 2006-03-24 2009-11-24 Norits, Inc. Method for creating perfusable microvessel systems
US8003388B2 (en) 2006-03-24 2011-08-23 Nortis, Inc. Method for creating perfusable microvessel systems
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
FR2902011B1 (fr) * 2006-06-12 2008-12-26 Inst Radioprot Et De Surete Nu Utilisation de fractions cellulaires du tissu adipeux pour la regeneration tissulaire post irradiation
MX2010003019A (es) 2007-09-19 2010-04-30 Pluristem Ltd Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
WO2010021993A1 (en) * 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US20130287745A1 (en) * 2010-02-15 2013-10-31 Keith Leonard March Compositions and methods to stimulate vascular structure formation
FI20115670A0 (fi) * 2011-06-23 2011-06-23 Tampereen Yliopisto Kardiovaskulaarinen in vitro-malli
JP6241890B2 (ja) * 2012-08-18 2017-12-06 国立大学法人 千葉大学 血管組織およびその作製方法
WO2016140716A1 (en) * 2015-03-02 2016-09-09 The Trustees Of Columbia University In The City Of New York Injectable microtissue systems, devices, and methods
JP2018087141A (ja) * 2015-03-27 2018-06-07 学校法人日本大学 脱分化脂肪細胞を有効成分とする血管再生療法用組成物
KR101812979B1 (ko) * 2015-07-10 2017-12-29 가톨릭대학교 산학협력단 동질성을 가지는 줄기세포 분획의 분리방법
JP7348612B2 (ja) * 2018-10-18 2023-09-21 学校法人日本大学 壊死性腸炎治療用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184035B1 (en) * 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
KR100979664B1 (ko) * 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 지방 유래 간세포 및 격자
FR2819265B1 (fr) * 2001-01-10 2004-01-02 Centre Nat Rech Scient Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques
CN100516200C (zh) * 2001-11-09 2009-07-22 阿特塞尔科学公司 用于角膜和眶内缺损修复的脂肪组织来源的基质细胞及其应用
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US20050250202A1 (en) * 2002-03-19 2005-11-10 March Keith L Adipose stromal stem cells for tissue and vascular modification
WO2005085422A1 (en) * 2004-02-27 2005-09-15 Michigan State University Adult stem cells and uses thereof

Also Published As

Publication number Publication date
FR2859381B1 (fr) 2008-07-25
JP2007504204A (ja) 2007-03-01
ES2378165T3 (es) 2012-04-09
US20070116674A1 (en) 2007-05-24
CA2537482C (fr) 2014-07-08
WO2005025584A1 (fr) 2005-03-24
EP1663263B1 (de) 2011-11-23
EP1663263A1 (de) 2006-06-07
CA2537482A1 (fr) 2005-03-24
FR2859381A1 (fr) 2005-03-11
JP4977463B2 (ja) 2012-07-18
US20120207722A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
ATE534395T1 (de) Verwendung von fettgewebezellen zur einleitung der bildung eines funktionalen gefässnetzes
Iohara et al. A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp
Kuhn et al. Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells
Vaculik et al. Human dermis harbors distinct mesenchymal stromal cell subsets
Mafi et al. Adult mesenchymal stem cells and cell surface characterization-a systematic review of the literature
Villadsen et al. Evidence for a stem cell hierarchy in the adult human breast
Girolamo et al. Human adipose-derived stem cells isolated from young and elderly women: their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation
Van Gastel et al. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells
Ning et al. Mesenchymal stem cell marker Stro-1 is a 75kd endothelial antigen
Ma et al. In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing
Szepesi et al. In vitro characterization of human mesenchymal stem cells isolated from different tissues with a potential to promote complex bone regeneration
Shoae‐Hassani et al. Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
Maioli et al. Osteogenesis from dental pulp derived stem cells: a novel conditioned medium including melatonin within a mixture of hyaluronic, butyric, and retinoic acids
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
NO20002979L (no) Undersøkelse av human papillomavirus-relatert sykdom
DE69910362D1 (de) Anwendung der mesenchymalen stammzellen als immunsuppressiva
James et al. Pericytes for the treatment of orthopedic conditions
ATE466072T1 (de) Bandscheibe
Markou et al. Tissue engineering using vascular organoids from human pluripotent stem cell derived mural cell phenotypes
Gilles et al. Epithelial‐to‐mesenchymal transition in HPV‐33‐transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A
Ogata et al. Anterior cruciate ligament-derived mesenchymal stromal cells have a propensity to differentiate into the ligament lineage
Herrmann et al. Bone marrow niches for skeletal progenitor cells and their inhabitants in health and disease
Hayes et al. Concise review: stem/progenitor cell proteoglycans decorated with 7-D-4, 4-C-3, and 3-B-3 (-) chondroitin sulfate motifs are morphogenetic markers of tissue development
Reichert et al. Ovine bone‐and marrow‐derived progenitor cells and their potential for scaffold‐based bone tissue engineering applications in vitro and in vivo